Literature DB >> 17272442

Antibiotic dosing before primary hip and knee replacement as a pay-for-performance measure.

Timothy Bhattacharyya1, David C Hooper.   

Abstract

BACKGROUND: There is a trend toward linking the reimbursement for health care services to clinical outcome. One such pay-for-performance proposal that affects orthopaedic surgeons is linking reimbursement for hip and knee replacements to measures such as the percentage of patients receiving antibiotics before surgery. We analyzed the risk factors associated with failing to optimally administer preoperative antibiotics before primary hip and knee arthroplasty.
METHODS: Data on 988 elective primary total hip and knee replacements done at one institution were collected. Multivariate analysis was performed to determine clinical factors associated with administration of antibiotics outside the recommended window (within one hour before the incision).
RESULTS: Thirteen percent of the patients did not receive optimal antibiotic therapy (within the one-hour window prior to the elective arthroplasty). Five patients (0.5%) received no documented preoperative antibiotics. Patients undergoing total hip arthroplasty were more likely to receive antibiotics outside the one-hour window than were patients undergoing total knee arthroplasty. Longer induction times were associated with administration of antibiotics outside the one-hour window. Certain individual surgeons and anesthesiologists were more likely to administer antibiotics on time. The anesthesiologist effect was more significant than the surgeon effect.
CONCLUSIONS: Approximately 13% of the patients did not receive optimal antibiotic therapy before total hip and knee replacement. Surgeons can improve their performance score for this measure by focusing antibiotic strategies on patients receiving a hip replacement and on complex cases, by developing systems for antibiotic dosing with the anesthesia team, and by improving documentation.

Entities:  

Mesh:

Year:  2007        PMID: 17272442     DOI: 10.2106/JBJS.F.00136

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  6 in total

1.  Antibiotic prophylaxis for total joint replacement surgery: results of a survey of Canadian orthopedic surgeons.

Authors:  Justin de Beer; Danielle Petruccelli; Coleman Rotstein; Brad Weening; Katie Royston; Mitch Winemaker
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

2.  Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States.

Authors:  Spencer S Liu; Alejandro González Della Valle; Melanie C Besculides; Licia K Gaber; Stavros G Memtsoudis
Journal:  Int Orthop       Date:  2008-05-07       Impact factor: 3.075

3.  Measuring quality in health care and its implications for pay-for-performance initiatives.

Authors:  Kevin C Chung; Melissa J Shauver
Journal:  Hand Clin       Date:  2009-02       Impact factor: 1.907

4.  [C-reactive protein. An independent risk factor for the development of infection after primary arthroplasty].

Authors:  T Pfitzner; D Krocker; C Perka; G Matziolis
Journal:  Orthopade       Date:  2008-11       Impact factor: 1.087

5.  Measuring the report card: the validity of pay-for-performance metrics in orthopedic surgery.

Authors:  Timothy Bhattacharyya; Andrew A Freiberg; Priyesh Mehta; Jeffrey Neil Katz; Timothy Ferris
Journal:  Health Aff (Millwood)       Date:  2009 Mar-Apr       Impact factor: 6.301

6.  Operating room environment and surgical site infections in arthroplasty procedures.

Authors:  M L Cristina; M Sartini; E Schinca; G Ottria; A M Spagnolo
Journal:  J Prev Med Hyg       Date:  2016-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.